Insider Trading activities of Bristol Myers Squibb Co insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bristol Myers Squibb Co since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bristol Myers Squibb Co since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Bristol Myers Squibb Co since 2005. The reporting company's ticker symbol is BMY. The reporting company's CIK number is 14272.
The total value of stock buying since 2005 is $4,193,656.
The total value of stock sales since 2005 is $331,421,840.
The total value of stock option exercises since 2005 is $173,557,589.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Bristol Myers Squibb Co insiders (BMY) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-04-01 Cornelius James M (Director) Sale 10,000 41.09 410,900
2013-03-27 Cornelius James M (Director) Sale 10,000 40.68 406,800
2013-03-26 Cornelius James M (Director) Sale 10,000 40.62 406,200
2013-03-21 Cornelius James M (Director) Sale 10,000 39.78 397,800
2013-03-20 Cornelius James M (Director) Sale 10,000 39.78 397,800
2013-03-13 Elicker John E (SVP Pub Affairs & Inv Relation) Sale 3,409 38.51 131,280
2013-03-13 Cuss Francis M (SVP Research) Sale 69,713 38.47 2,681,859
2013-03-13 Cuss Francis M (SVP Research) Option Ex 84,952 21.62 1,836,662
2013-03-13 Cornelius James M (Director) Sale 10,000 38.34 383,400
2013-03-12 Cornelius James M (Director) Sale 10,000 38.02 380,200
2013-03-08 Cornelius James M (Director) Sale 10,000 37.41 374,099
2013-03-07 Moed Samuel J (SVP, Strat Plan & Analysis) Option Ex 14,425 .00 0
2013-03-07 Elicker John E (SVP Pub Affairs & Inv Relation) Option Ex 15,169 .00 0
2013-03-07 Caforio Giovanni (Pres., US Pharmaceuticals) Option Ex 15,482 .00 0
2013-03-07 Schmukler Louis S (Pres., Global Mfg. & Supply) Option Ex 2,528 .00 0
2013-03-07 Von Autenried Paul (SVP, Enterp. Services & CIO) Option Ex 21,975 .00 0
2013-03-07 Cuss Francis M (SVP Research) Option Ex 45,017 .00 0
2013-03-07 Bancroft Charles A (EVP & Chief Financial Officer) Option Ex 69,542 .00 0
2013-03-07 Cazala Beatrice J (EVP Commercial Operations) Sale 83,750 37.61 3,149,837
2013-03-07 Cazala Beatrice J (EVP Commercial Operations) Option Ex 179,678 4.95 889,046
2013-03-07 Daniels Brian (SVP Global Dev & Med Affairs) Option Ex 42,070 .00 0
2013-03-07 Caldarella Joseph C (SVP & Controller) Option Ex 20,808 .00 0
2013-03-07 Andreotti Lamberto (Chief Executive Officer) Option Ex 330,160 .00 0
2013-03-07 Sigal Elliot (EVP, CSO & President R&D) Option Ex 132,390 .00 0
2013-03-07 Leung Sandra (General Counsel & Secretary) Option Ex 81,203 .00 0
2013-03-07 Cornelius James M (Director) Sale 10,000 37.67 376,700
2013-03-06 Cazala Beatrice J (EVP Commercial Operations) Option Ex 3,595 .00 0
2013-03-04 Daniels Brian (SVP Global Dev & Med Affairs) Option Ex 1,870 .00 0
2013-03-04 Andreotti Lamberto (Chief Executive Officer) Option Ex 7,453 .00 0
2013-03-04 Sigal Elliot (EVP, CSO & President R&D) Option Ex 7,453 .00 0
2013-03-04 Leung Sandra (General Counsel & Secretary) Option Ex 3,980 .00 0
2013-03-03 Moed Samuel J (SVP, Strat Plan & Analysis) Option Ex 1,936 .00 0
2013-03-03 Elicker John E (SVP Pub Affairs & Inv Relation) Option Ex 1,851 .00 0
2013-03-03 Caforio Giovanni (Pres., US Pharmaceuticals) Option Ex 1,851 .00 0
2013-03-03 Von Autenried Paul (SVP, Enterp. Services & CIO) Option Ex 2,422 .00 0
2013-03-03 Cuss Francis M (SVP Research) Option Ex 3,753 .00 0
2013-03-03 Bancroft Charles A (EVP & Chief Financial Officer) Option Ex 2,487 .00 0
2013-03-03 Daniels Brian (SVP Global Dev & Med Affairs) Option Ex 2,691 .00 0
2013-03-03 Caldarella Joseph C (SVP & Controller) Option Ex 2,379 .00 0
2013-03-03 Andreotti Lamberto (Chief Executive Officer) Option Ex 10,344 .00 0
2013-03-03 Sigal Elliot (EVP, CSO & President R&D) Option Ex 46,365 .00 0
2013-03-03 Leung Sandra (General Counsel & Secretary) Option Ex 4,793 .00 0
2013-02-27 Caforio Giovanni (Pres., US Pharmaceuticals) Sale 12,150 37.08 450,522
2013-02-26 Cornelius James M (Director) Sale 10,000 36.44 364,400
2013-02-25 Cornelius James M (Director) Sale 10,000 36.71 367,100
2013-02-21 Cornelius James M (Director) Sale 10,000 36.67 366,700
2013-02-20 Caldarella Joseph C (SVP & Controller) Sale 37,585 36.87 1,385,758
2013-02-20 Caldarella Joseph C (SVP & Controller) Option Ex 40,308 24.87 1,002,459
2013-02-20 Cornelius James M (Director) Sale 10,000 36.87 368,700
2013-02-13 Cornelius James M (Director) Sale 10,000 36.15 361,500
2013-02-12 Cornelius James M (Director) Sale 10,000 36.68 366,800
2013-02-11 Elicker John E (SVP Pub Affairs & Inv Relation) Sale 15,264 36.98 564,386
2013-02-11 Elicker John E (SVP Pub Affairs & Inv Relation) Option Ex 16,875 28.11 474,356
2013-02-08 Sigal Elliot (EVP, CSO & President R&D) Sale 224,705 36.79 8,266,896
2013-02-08 Sigal Elliot (EVP, CSO & President R&D) Option Ex 266,082 22.78 6,062,146
2013-02-07 Cornelius James M (Director) Sale 10,000 36.42 364,200
2013-02-06 Cornelius James M (Director) Sale 10,000 36.51 365,100
2013-02-05 Leung Sandra (General Counsel & Secretary) Sale 16,780 36.87 618,678
2013-02-05 Leung Sandra (General Counsel & Secretary) Option Ex 19,310 23.14 446,833
2013-02-04 Von Autenried Paul (SVP & CIO) Sale 50,300 36.67 1,844,501
2013-02-04 Von Autenried Paul (SVP & CIO) Option Ex 56,212 25.75 1,447,627
2013-02-04 Campbell Lewis B (Director) Sale 3,500 36.77 128,695
2013-02-04 Campbell Lewis B (Director) Option Ex 3,500 25.51 89,285
2013-01-31 Daniels Brian (SVP Global Dev & Med Affairs) Sale 12,000 36.22 434,640
2013-01-30 Glimcher Laurie H M.d. (Director) Sale 11,000 36.40 400,400
2013-01-30 Glimcher Laurie H M.d. (Director) Option Ex 11,000 25.61 281,655
2013-01-29 Cornelius James M (Director) Sale 10,000 36.53 365,300
2013-01-28 Caforio Giovanni (Pres., US Pharmaceuticals) Sale 20,350 36.19 736,466
2013-01-28 Caforio Giovanni (Pres., US Pharmaceuticals) Option Ex 22,500 28.67 645,075
2013-01-28 Cornelius James M (Director) Sale 10,000 36.43 364,300
2013-01-25 Cornelius James M (Director) Sale 10,000 36.32 363,200
2013-01-24 Cornelius James M (Director) Sale 10,000 35.34 353,450
2013-01-17 Cornelius James M (Director) Sale 10,000 34.33 343,300
2013-01-16 Cornelius James M (Director) Sale 10,000 34.33 343,300
2013-01-08 Cornelius James M (Director) Sale 10,000 33.58 335,800
2013-01-07 Cornelius James M (Director) Sale 10,000 33.40 334,000
2013-01-04 Cornelius James M (Director) Sale 10,000 33.26 332,600
2013-01-03 Caforio Giovanni (Pres., US Pharmaceuticals) Option Ex 7,500 .00 0
2013-01-03 Cornelius James M (Director) Sale 10,000 32.98 329,799
2012-12-28 Cornelius James M (Director) Sale 10,000 32.09 320,900
2012-12-27 Cornelius James M (Director) Sale 10,000 32.02 320,200
2012-12-21 Cornelius James M (Director) Sale 10,000 32.48 324,799
2012-12-20 Cornelius James M (Director) Sale 10,000 32.52 325,200
2012-12-17 Bancroft Charles A (EVP & Chief Financial Officer) Sale 42,844 32.77 1,403,997
2012-12-17 Bancroft Charles A (EVP & Chief Financial Officer) Option Ex 47,125 25.62 1,207,578
2012-12-12 Cornelius James M (Director) Sale 10,000 33.31 333,100
2012-12-11 Sigal Elliot (EVP, CSO & President R&D) Sale 157,257 33.00 5,189,481
2012-12-11 Cornelius James M (Director) Sale 10,000 33.10 331,000
2012-12-04 Cornelius James M (Director) Sale 10,000 32.64 326,400
2012-12-03 Cornelius James M (Director) Sale 10,000 32.68 326,800
2012-11-28 Cornelius James M (Director) Sale 10,000 32.58 325,800
2012-11-27 Cornelius James M (Director) Sale 10,000 32.69 326,900
2012-11-20 Cornelius James M (Director) Sale 10,000 32.04 320,400
2012-11-19 Cornelius James M (Director) Sale 10,000 31.90 319,000
2012-11-14 Cornelius James M (Director) Sale 10,000 31.65 316,500
2012-11-13 Cornelius James M (Director) Sale 10,000 32.04 320,400
2012-11-06 Cornelius James M (Director) Sale 10,000 33.27 332,700
2012-11-05 Cornelius James M (Director) Sale 10,000 33.11 331,100
2012-11-02 Cuss Francis M (SVP Research) Option Ex 6,668 .00 0
2012-10-26 Elicker John E (SVP Pub Affairs & Inv Relation) Sale 2,214 33.55 74,279
2012-10-23 Cornelius James M (Director) Sale 10,000 33.26 332,600
2012-10-22 Cornelius James M (Director) Sale 10,000 33.81 338,100
2012-10-17 Cornelius James M (Director) Sale 10,000 34.34 343,400
2012-10-16 Cornelius James M (Director) Sale 10,000 34.15 341,500
2012-10-12 Cornelius James M (Director) Sale 10,000 33.08 330,800
2012-10-11 Cornelius James M (Director) Sale 10,000 33.06 330,600
2012-10-03 Schmukler Louis S (Pres., Global Manufacturing &) Option Ex 13,933 .00 0
2012-10-03 Cornelius James M (Director) Sale 10,000 33.53 335,300
2012-10-02 Cornelius James M (Director) Sale 10,000 33.88 338,800
2012-09-28 Cornelius James M (Director) Sale 10,000 33.75 337,500
2012-09-27 Cornelius James M (Director) Sale 10,000 33.88 338,800
2012-09-19 Cornelius James M (Director) Sale 10,000 32.97 329,700
2012-09-18 Cornelius James M (Director) Sale 10,000 32.98 329,799
2012-09-07 Caldarella Joseph C (SVP & Controller) Sale 22,155 33.16 734,659
2012-09-07 Caldarella Joseph C (SVP & Controller) Option Ex 16,500 28.11 463,815
2012-09-05 Andreotti Lamberto (Chief Executive Officer) Sale 115,500 33.05 3,817,274
2012-09-05 Andreotti Lamberto (Chief Executive Officer) Option Ex 135,000 23.14 3,123,900
2012-08-30 Cuss Francis M (SVP Research) Sale 118,190 32.89 3,887,269
2012-08-30 Cuss Francis M (SVP Research) Option Ex 147,618 20.79 3,069,421
2012-08-24 Caforio Giovanni (Pres., US Pharmaceuticals) Sale 25,900 32.69 846,670
2012-08-24 Caforio Giovanni (Pres., US Pharmaceuticals) Option Ex 30,458 23.18 705,925
2012-08-14 Cornelius James M (Director) Sale 5,000 31.60 158,000
2012-08-13 Cornelius James M (Director) Sale 5,000 31.56 157,800
2012-08-10 Cazala Beatrice J (EVP Commercial Operations) Sale 143,600 31.79 4,565,044
2012-08-10 Cazala Beatrice J (EVP Commercial Operations) Option Ex 156,662 24.84 3,892,267
2012-08-10 Daniels Brian (SVP Global Dev & Med Affairs) Sale 79,900 31.72 2,534,428
2012-08-10 Daniels Brian (SVP Global Dev & Med Affairs) Option Ex 77,545 20.32 1,576,102
2012-08-10 Cornelius James M (Director) Sale 5,000 31.76 158,800
2012-08-09 Cornelius James M (Director) Sale 5,000 31.85 159,250
2012-08-02 Cornelius James M (Director) Sale 5,000 32.81 164,050
2012-08-01 Cornelius James M (Director) Sale 5,000 35.84 179,200
2012-07-26 Cornelius James M (Director) Sale 5,000 35.74 178,700
2012-07-25 Cornelius James M (Director) Sale 5,000 34.84 174,200
2012-07-19 Cornelius James M (Director) Sale 5,000 36.07 180,350
2012-07-18 Cornelius James M (Director) Sale 5,000 36.04 180,200
2012-07-13 Cornelius James M (Director) Sale 5,000 35.35 176,750
2012-07-12 Cornelius James M (Director) Sale 5,000 34.85 174,250
2012-07-03 Cornelius James M (Director) Sale 5,000 35.04 175,200
2012-07-02 Cornelius James M (Director) Sale 5,000 35.93 179,650
2012-06-27 Cornelius James M (Director) Sale 5,000 35.07 175,350
2012-06-26 Cornelius James M (Director) Sale 5,000 34.54 172,700
2012-06-22 Cornelius James M (Director) Sale 5,000 34.99 174,950
2012-06-21 Cornelius James M (Director) Sale 5,000 34.84 174,200
2012-06-15 Cornelius James M (Director) Sale 5,000 34.45 172,250
2012-06-14 Cornelius James M (Director) Sale 5,000 34.55 172,750
2012-06-06 Cornelius James M (Director) Sale 5,000 33.98 169,899
2012-06-05 Cornelius James M (Director) Sale 5,000 33.69 168,450
2012-05-30 Cornelius James M (Director) Sale 5,000 33.49 167,450
2012-05-29 Cornelius James M (Director) Sale 5,000 33.29 166,450
2012-05-23 Cornelius James M (Director) Sale 5,000 32.48 162,399
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of BMY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bristol Myers Squibb Co (symbol BMY, CIK number 14272) see the Securities and Exchange Commission (SEC) website.